1. Home
  2. RAIL vs TLSA Comparison

RAIL vs TLSA Comparison

Compare RAIL & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FreightCar America Inc.

RAIL

FreightCar America Inc.

HOLD

Current Price

$8.40

Market Cap

186.1M

Sector

Industrials

ML Signal

HOLD

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

HOLD

Current Price

$1.69

Market Cap

206.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RAIL
TLSA
Founded
1901
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Railroads
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
186.1M
206.8M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
RAIL
TLSA
Price
$8.40
$1.69
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
156.3K
236.7K
Earning Date
11-10-2025
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.45
N/A
Revenue
$513,120,000.00
N/A
Revenue This Year
$2.94
N/A
Revenue Next Year
$6.92
N/A
P/E Ratio
$3.35
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.31
$0.63
52 Week High
$13.64
$2.60

Technical Indicators

Market Signals
Indicator
RAIL
TLSA
Relative Strength Index (RSI) 50.55 44.27
Support Level $7.27 $1.66
Resistance Level $7.94 $1.90
Average True Range (ATR) 0.34 0.15
MACD 0.09 0.01
Stochastic Oscillator 78.47 51.35

Price Performance

Historical Comparison
RAIL
TLSA

About RAIL FreightCar America Inc.

FreightCar America Inc is a manufacturer of railcars and components, serving diverse transportation needs in North America. The company designs and produces a wide range of railcar types, including box cars, hoppers, covered hoppers, gondolas, and flat cars for both intermodal and non-intermodal freight. The company has two segments: The Manufacturing segment encompasses new railcar manufacturing, used railcar sales, leasing, and rebuilds, while the Aftermarket segment includes the selling of forged, cast and fabricated railcar parts and supplies for all railcar types, and provides aftermarket services including safety training, railcar inspections, and preventative maintenance. The company's revenue is predominantly derived from its Manufacturing segment.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

Share on Social Networks: